Stock Events

Stock Events

Venus Medtech (Hangzhou) 

$0.42
1
+$0.12+41.58% Monday 20:21

Statistics

Day High
0.42
Day Low
0.42
52W High
0.52
52W Low
0.21
Volume
1,000
Avg. Volume
16
Mkt Cap
186.06M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

31MarExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Next
-0.08
-0.07
-0.06
-0.04
Expected EPS
-0.042888
Actual EPS
N/A

Financials

-151.65%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
129.18MRevenue
-195.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VMTHF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences is a leading developer of heart valve systems and repair products, directly competing in the transcatheter heart valve market.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers extensive cardiac and vascular therapies, including transcatheter valves, competing in the same space as Venus Medtech.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific produces interventional cardiology products, including transcatheter valves, which are in direct competition with Venus Medtech's offerings.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories provides a range of cardiovascular devices, including transcatheter valve repair and replacement technologies.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies, including surgical equipment and orthopedics, and is expanding into cardiac interventions.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet, primarily known for orthopedic devices, has been moving into the cardiovascular space, potentially competing in future.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences manufactures medical devices, including products for cardiac surgery, competing in the broader market for cardiovascular treatments.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical is primarily focused on spine and orthopedics but is venturing into new medical device territories, including cardiovascular interventions.

About

Venus Medtech (Hangzhou) Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of brain damage and prevent cerebral embolism during TAVR and other structural heart disease surgeries. It also develops VenusA-Plus and VenusA-Pilot, which are TAVR product candidates; and transcatheter mitral and tricuspid valve replacement products; Liwen RF ablation system for the treatment of hypertrophic cardiomyopathy; and renal denervation for the treatment of hypertension. The company was founded in 2009 and is headquartered in Hangzhou, the People's Republic of China.
Show more...
CEO
Mr. Hou-Sen Lim MEng.
Employees
691
Country
US
ISIN
CNE100003PJ8

Listings

OTC Link
US
VMTHF
HK
HK
2500.HK

0 Comments

Share your thoughts

FAQ

What is Venus Medtech (Hangzhou) stock price today?▼
The current price of VMTHF is $0.42 USD — it has increased by +41.58% in the past 24 hours. Watch Venus Medtech (Hangzhou) stock price performance more closely on the chart.
What is Venus Medtech (Hangzhou) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Venus Medtech (Hangzhou) stocks are traded under the ticker VMTHF.
What is Venus Medtech (Hangzhou) market cap?▼
Today Venus Medtech (Hangzhou) has the market capitalization of 186.06M
When is the next Venus Medtech (Hangzhou) earnings date?▼
Venus Medtech (Hangzhou) is going to release the next earnings report on August 27, 2026.
What is Venus Medtech (Hangzhou) revenue for the last year?▼
Venus Medtech (Hangzhou) revenue for the last year amounts to 129.18M USD.
What is Venus Medtech (Hangzhou) net income for the last year?▼
VMTHF net income for the last year is -195.9M USD.
How many employees does Venus Medtech (Hangzhou) have?▼
As of April 01, 2026, the company has 691 employees.
In which sector is Venus Medtech (Hangzhou) located?▼
Venus Medtech (Hangzhou) operates in the Health Care sector.
When did Venus Medtech (Hangzhou) complete a stock split?▼
Venus Medtech (Hangzhou) has not had any recent stock splits.
Where is Venus Medtech (Hangzhou) headquartered?▼
Venus Medtech (Hangzhou) is headquartered in Hangzhou, US.